Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes

Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes

We report a case of acute-onset type 1 diabetes due to combined application of nivolumab and intravesical Bacillus Calmette-Guérin (BCG). An 84-year-old woman underwent lung resection for pulmonary squamous cell carcinoma. She had been treated for type 2 diabetes and later experienced lung cancer re...

Full description

Bibliographic Details
Main Authors: Koichi Fujiu, Yasuo Fukaya, Masahiro Kamimoto, Hideaki Miyamoto, Yue Cong, Hiroyuki Suzuki
Format: Article
Language:English
Published: Karger Publishers 2019-06-01
Series:Case Reports in Oncology
Subjects:
Type 1 diabetes
Nivolumab
Lung cancer
Intravesical BCG
PD-L1
Online Access:https://www.karger.com/Article/FullText/500978

Internet

https://www.karger.com/Article/FullText/500978

Similar Items